• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FXR 缺陷型衰老小鼠表现出能量消耗增加、葡萄糖控制改善和类似于 NASH 的肝损伤。

Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.

机构信息

AstraZeneca R&D, Mölndal, Sweden.

出版信息

PLoS One. 2013 May 20;8(5):e64721. doi: 10.1371/journal.pone.0064721. Print 2013.

DOI:10.1371/journal.pone.0064721
PMID:23700488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3659114/
Abstract

Nuclear receptor subfamily 1, group H, member 4 (Nr1h4, FXR) is a bile acid activated nuclear receptor mainly expressed in the liver, intestine, kidney and adrenal glands. Upon activation, the primary function is to suppress cholesterol 7 alpha-hydroxylase (Cyp7a1), the rate-limiting enzyme in the classic or neutral bile acid synthesis pathway. In the present study, a novel Fxr deficient mouse line was created and studied with respect to metabolism and liver function in ageing mice fed chow diet. The Fxr deficient mice were similar to wild type mice in terms of body weight, body composition, energy intake and expenditure as well as behaviours at a young age. However, from 15 weeks of age and onwards, the Fxr deficient mice had almost no body weight increase up to 39 weeks of age mainly because of lower body fat mass. The lower body weight gain was associated with increased energy expenditure that was not compensated by increased food intake. Fasting levels of glucose and insulin were lower and glucose tolerance was improved in old and lean Fxr deficient mice. However, the Fxr deficient mice displayed significantly increased liver weight, steatosis, hepatocyte ballooning degeneration and lobular inflammation together with elevated plasma levels of ALT, bilirubin and bile acids, findings compatible with non-alcoholic steatohepatitis (NASH) and cholestasis. In conclusion, ageing Fxr deficient mice display late onset leanness associated with elevated energy expenditure and improved glucose control but develop severe NASH-like liver pathology.

摘要

核受体亚家族 1,组 H,成员 4(Nr1h4,FXR)是一种胆汁酸激活的核受体,主要在肝脏、肠道、肾脏和肾上腺中表达。激活后,主要功能是抑制胆固醇 7α-羟化酶(Cyp7a1),这是经典或中性胆汁酸合成途径中的限速酶。在本研究中,创建了一种新型的 Fxr 缺陷小鼠品系,并研究了其在给予普通饮食的老化小鼠中的代谢和肝功能。在年轻时期,Fxr 缺陷小鼠在体重、体成分、能量摄入和支出以及行为方面与野生型小鼠相似。然而,从 15 周龄开始,Fxr 缺陷小鼠的体重几乎没有增加,直到 39 周龄,主要是因为体脂肪量减少。体重增加减少与能量消耗增加有关,而能量消耗增加并没有通过增加食物摄入来补偿。老年和瘦的 Fxr 缺陷小鼠的空腹血糖和胰岛素水平较低,葡萄糖耐量改善。然而,Fxr 缺陷小鼠表现出明显增加的肝重、脂肪变性、肝细胞气球样变性和肝小叶炎症,以及升高的血浆丙氨酸氨基转移酶(ALT)、胆红素和胆汁酸水平,这些发现与非酒精性脂肪性肝炎(NASH)和胆汁淤积相符。总之,老化的 Fxr 缺陷小鼠表现出迟发性消瘦,伴有能量消耗增加和葡萄糖控制改善,但发展出严重的 NASH 样肝病理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/b49350588e4b/pone.0064721.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/e1215ea605ac/pone.0064721.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/1a70ae8c3286/pone.0064721.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/966fe2bde856/pone.0064721.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/e5638609a34f/pone.0064721.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/d969103bd20b/pone.0064721.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/9b299eed70c8/pone.0064721.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/ee3b0286e079/pone.0064721.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/b49350588e4b/pone.0064721.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/e1215ea605ac/pone.0064721.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/1a70ae8c3286/pone.0064721.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/966fe2bde856/pone.0064721.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/e5638609a34f/pone.0064721.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/d969103bd20b/pone.0064721.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/9b299eed70c8/pone.0064721.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/ee3b0286e079/pone.0064721.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/3659114/b49350588e4b/pone.0064721.g008.jpg

相似文献

1
Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.FXR 缺陷型衰老小鼠表现出能量消耗增加、葡萄糖控制改善和类似于 NASH 的肝损伤。
PLoS One. 2013 May 20;8(5):e64721. doi: 10.1371/journal.pone.0064721. Print 2013.
2
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.肝细胞髓样分化因子88影响胆汁酸、肠道微生物群和代谢组,有助于调节葡萄糖和脂质代谢。
Gut. 2017 Apr;66(4):620-632. doi: 10.1136/gutjnl-2015-310904. Epub 2016 May 5.
3
Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.过量胆汁酸激活核因子-κB并促进法尼酯X受体缺陷小鼠酒精性脂肪性肝炎的发展。
Biochimie. 2015 Aug;115:86-92. doi: 10.1016/j.biochi.2015.05.014. Epub 2015 May 27.
4
Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.肝脏FXR/SHP轴调节老年小鼠的全身葡萄糖和脂肪酸稳态。
Hepatology. 2017 Aug;66(2):498-509. doi: 10.1002/hep.29199. Epub 2017 Jun 26.
5
Microbiota-induced obesity requires farnesoid X receptor.微生物群诱导的肥胖需要法尼醇X受体。
Gut. 2017 Mar;66(3):429-437. doi: 10.1136/gutjnl-2015-310283. Epub 2016 Jan 6.
6
Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.法尼酯X受体有助于饮食诱导肥胖小鼠行Roux-en-Y胃旁路手术后血糖控制的改善,且这种改善与体重无关。
Mol Metab. 2020 Jul;37:100980. doi: 10.1016/j.molmet.2020.100980. Epub 2020 Mar 19.
7
Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.法尼酯X受体缺乏在喂食高脂饮食的低密度脂蛋白受体敲除小鼠中诱发非酒精性脂肪性肝炎。
J Pharmacol Exp Ther. 2009 Jan;328(1):116-22. doi: 10.1124/jpet.108.144600. Epub 2008 Oct 23.
8
Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.高脂饮食喂养的游离脂肪酸受体 2 缺陷小鼠血糖控制改善和体脂肪量减少。
Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E211-20. doi: 10.1152/ajpendo.00229.2010. Epub 2010 Oct 19.
9
Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.FXR缺失可预防饮食诱导的肥胖,并加速ob/ob小鼠的肝癌发生。
Mol Endocrinol. 2012 Feb;26(2):272-80. doi: 10.1210/me.2011-1157. Epub 2012 Jan 19.
10
Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.胆汁酸可逆转法尼醇 X 受体缺陷小鼠非酒精性脂肪性肝炎模型中的脂肪变性。
Biochem Biophys Res Commun. 2014 May 23;448(1):50-5. doi: 10.1016/j.bbrc.2014.04.048. Epub 2014 Apr 18.

引用本文的文献

1
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的抗纤维化治疗
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
2
Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy.肝脏代谢的十字路口:营养感应核受体与自噬的相互调控
Int J Mol Sci. 2025 Jun 18;26(12):5825. doi: 10.3390/ijms26125825.
3
Liver-specific Nr1h4 deletion in mice with human-like bile acid composition causes severe liver injury.

本文引用的文献

1
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的动物模型。
World J Gastroenterol. 2012 May 21;18(19):2300-8. doi: 10.3748/wjg.v18.i19.2300.
2
Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.胆汁酸通过法尼醇 X 受体激活和 KATP 通道抑制,急性刺激小鼠β细胞胰岛素分泌。
Diabetes. 2012 Jun;61(6):1479-89. doi: 10.2337/db11-0815. Epub 2012 Apr 9.
3
Reversal of type 1 diabetes in mice by brown adipose tissue transplant.
在具有类人胆汁酸组成的小鼠中肝脏特异性Nr1h4缺失会导致严重肝损伤。
J Lipid Res. 2025 Jul;66(7):100839. doi: 10.1016/j.jlr.2025.100839. Epub 2025 Jun 9.
4
Targeting farnesoid X receptor as aging intervention therapy.以法尼醇X受体为靶点的衰老干预疗法。
Acta Pharm Sin B. 2025 Mar;15(3):1359-1382. doi: 10.1016/j.apsb.2025.01.006. Epub 2025 Jan 19.
5
Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model.治疗批准的个体胆汁酸对代谢功能障碍相关脂肪性肝炎 a 低胆汁酸小鼠模型发展的影响。
Toxicol Sci. 2024 Dec 1;202(2):179-195. doi: 10.1093/toxsci/kfae110.
6
Nutrition at the Intersection between Gut Microbiota Eubiosis and Effective Management of Type 2 Diabetes.肠道微生物群稳态与 2 型糖尿病有效管理之间的营养作用
Nutrients. 2024 Jan 16;16(2):269. doi: 10.3390/nu16020269.
7
Roles of gut microbes in metabolic-associated fatty liver disease.肠道微生物在代谢相关脂肪性肝病中的作用。
Tzu Chi Med J. 2023 Jul 11;35(4):279-289. doi: 10.4103/tcmj.tcmj_86_23. eCollection 2023 Oct-Dec.
8
The Role of the Nuclear Receptor FXR in Arsenic-Induced Glucose Intolerance in Mice.核受体FXR在小鼠砷诱导的葡萄糖不耐受中的作用
Toxics. 2023 Oct 1;11(10):833. doi: 10.3390/toxics11100833.
9
Evaluation of the correlation between fetuin-B levels and essential hypertension: a cross-sectional study.胎球蛋白-B水平与原发性高血压之间的相关性评估:一项横断面研究。
Endocr Connect. 2023 Nov 8;12(12). doi: 10.1530/EC-23-0172. Print 2023 Dec 1.
10
Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy.改善非酒精性脂肪性肝病治疗中潜在候选药物成药性的药学策略。
Pharmaceutics. 2023 Jul 16;15(7):1963. doi: 10.3390/pharmaceutics15071963.
通过棕色脂肪组织移植逆转小鼠 1 型糖尿病。
Diabetes. 2012 Mar;61(3):674-82. doi: 10.2337/db11-0510. Epub 2012 Feb 7.
4
Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.FXR缺失可预防饮食诱导的肥胖,并加速ob/ob小鼠的肝癌发生。
Mol Endocrinol. 2012 Feb;26(2):272-80. doi: 10.1210/me.2011-1157. Epub 2012 Jan 19.
5
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.Toll 样受体 4 通过激活小鼠 X 盒结合蛋白 1 介导肥胖诱导的非酒精性脂肪性肝炎。
Gut. 2012 Jul;61(7):1058-67. doi: 10.1136/gutjnl-2011-300269. Epub 2012 Jan 17.
6
Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice.食用大豆分离蛋白可降低野生型小鼠肝脏中SREBP-1c和脂肪生成基因的表达,但对FXR基因缺陷型小鼠则无此作用。
Biosci Biotechnol Biochem. 2011;75(9):1702-7. doi: 10.1271/bbb.110224. Epub 2011 Sep 7.
7
Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.法尼醇 X 受体 (FXR) 在骨髓基质细胞向成骨细胞分化过程中的作用。
Bone. 2011 Dec;49(6):1219-31. doi: 10.1016/j.bone.2011.08.013. Epub 2011 Aug 26.
8
Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.法尼醇 X 受体可保护人类和鼠类胃上皮细胞免受炎症诱导的损伤。
Biochem J. 2011 Sep 1;438(2):315-23. doi: 10.1042/BJ20102096.
9
Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.法尼醇 X 受体缺失可改善肥胖症小鼠模型的葡萄糖稳态。
Diabetes. 2011 Jul;60(7):1861-71. doi: 10.2337/db11-0030. Epub 2011 May 18.
10
Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model.Bach1 基因敲除可减轻 MCD 饮食诱导的小鼠脂肪性肝炎。
J Clin Biochem Nutr. 2011 Mar;48(2):161-6. doi: 10.3164/jcbn.09-122GFR. Epub 2010 Apr 10.